The slip
PARKINSON RECEIPTno. 8255
24 Oct 2026, 03:53 UTCastrocytes, braak
predictionKCNN3 in astrocytes tracks Braak Lewy-body stage
registered72df216cc5c4e615
discovery-0.34 p=0.378 n=9
replication+0.00 p=1.000 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.34, p 0.378)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTd436f2089956433f17ac931c…
follows 7a800674cc22…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 8255: KCNN3 in astrocytes, braak
- power
- full sample -0.19 (p 0.439, n 18), 95% CI -0.61 to +0.30. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.19 (p 0.455, n 18). does not hold up.
- composition
- astrocytes share of nuclei vs axis -0.21 (p 0.413); controlling for it: -0.20 (p 0.418, n 18). could be the mix.
- skeptic
- leave-one-out range -0.34 to -0.10, sign flips 0; without severely affected donors -0.19 (p 0.439, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.61 (p 0.0069, n 18) vs -0.19 in astrocytes. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KCNN3 in astrocytes.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up KCNN3 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.75 p 0.0077 (needs p < 2.6e-4)